PATENT CLAIM ANALYSIS

Application Number: 16228308
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "257000"]

Abstract:
This invention is in the area of improved compounds and methods for treating selected cancers and hyperproliferative disorders.

Claim (Index 13):
The method of  claim 9 , wherein the T-cell lymphoma is a Non-Hodgkin Lymphoma.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14212911', '14212430', '15342990', '15457699', '15943278']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7703319241987019
- 35 USC 102 Novelty (BERT): 0.5381192121447077
- Combined Prediction Score: 0.7471106529933025
- Mean Citation Score: 349.898738
- Max Citation Score: 354.42734
- Similarity Product: 246.34852566543583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test